Europe HbA1c Testing Market Research Report – Segmented By Type, Technology, End User and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)
Europe HbA1c Testing Market Size (2022 to 2027)
The size of the Europe HbA1c Testing market is anticipated to grow at 11.32% CAGR from 2022 to 2027. The European market was estimated to be valued at USD 356.22 Million in 2022 and is expected to reach USD 608.96 Million by 2027.
Due to poor food choices, a lack of physical activity, and excessive stress levels, the number of people affected by diabetes grows significantly with each passing day. Consequently, physicians are increasingly recommending HbA1c tests to their patients, which is likely to boost HbA1c Testing market revenue. Furthermore, the introduction of point-of-care and other novel gadgets to reduce the cost of diabetes testing is expected to boost the HbA1c Testing Market's growth.
The senior population is growing rapidly in the European region, increasing diabetes patient accounts worldwide. Because of technology improvements, novel testing methodologies and portable devices are projected to emerge, providing attractive prospects for HbA1c testing market participants. The expanding scope of medical tourism in developing countries is likely to boost the market for HbA1c testing. The market's key participants are projected to benefit from rising public awareness of the need to effectively controlling diabetes.
Rising patient footfall is predicted to boost the affordability of testing equipment in hospitals during the forecast period, resulting in more opportunities for the HbA1c testing market to grow. In the long run, the prevalence of early illness diagnoses among people is also fuelling market demand. These factors are positively impacting the market during the forecast period.
The testing equipment is expensive. In underdeveloped nations, the adoption of these technologies is low, which is projected to hamper the growth of the HbA1c testing market. The high manufacturing costs of these devices have resulted in limited production of HbA1c testing devices, offering a challenge to the HbA1c market's major competitors. Inaccuracies in testing due to disparities in interpretations are another key obstacle projected to impede market progress over the forecast period. Government restrictions and guidelines may have a detrimental influence on the HbA1c Testing Market's growth rate. Europe HbA1c Testing market is expected to be restrained by these limitations.
This research report on the European HbA1c Testing market has been segmented and sub-segmented into the following categories.
By Technology:
- Ion-Exchange HPCL
- Enzymatic Assay
- Affinity Binding Chromatography
- Turbidimetric Inhibition Immunoassay
- Other
By Type:
- Hand-Held Devices
- Bench Top Devices
By End User:
- Hospital
- Home Care
- Diagnostic laboratory
- Research Institutions
By Country:
- UK
- France
- Spain
- Germany
- Italy
- Russia
- Sweden
- Denmark
- Switzerland
- Netherlands
- Turkey
- Czech Republic
- Rest of Europe
Due to the increased use of modern diagnostic tools and devices, as well as strategic initiatives such as collaborations and agreements by prominent vital players, Europe is expected to have the second-largest market share.
Due to the progressive growth in the adoption of sophisticated diagnostic tools by medical professionals, the HbA1c testing market in Europe is expected to see a significant increase throughout the review period. They also provide funds for developing models that provide a better patient experience. Furthermore, in the years ahead, an increase in the availability of molecular diagnostic test kits and incremental developments in precision medicine might contribute to the market's geographical expansion.
The UK is expected to lead the European market during the forecast period. Increasing demand for portable analyzers and the proliferation of diagnostic facilities in rural areas of nations are projected to fuel the HbA1c market's expansion during the forecast period.
Following the United Kingdom, Germany is predicted to have the largest share of the European HbA1c Testing market. The hba1c testing market is rapidly expanding, and leading market players are likely to benefit from several growth prospects throughout the forecast period.
KEY MARKET PLAYERS:
Some of the key players operating in the market are Transasia Biomedicals ltd., Abbott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare, and Trinity Biotech plc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Technology
5.1.1 Introduction
5.1.2 Ion-Exchange HPCL
5.1.3 Enzymatic Assay
5.1.4 Affinity Binding Chromatography
5.1.5 Turbidimetric Inhibition Immunoassay
5.1.6 Other
5.1.7 Y-o-Y Growth Analysis, By Technology
5.1.8 Market Attractiveness Analysis, By Technology
5.1.9 Market Share Analysis, By Technology
5.2 Type
5.2.1 Introduction
5.2.2 Hand Held Devices
5.2.3 Bench Top Devices
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
5.3 End User
5.3.1 Introduction
5.3.2 Hospital
5.3.3 Home Care
5.3.4 Diagnostic laboratory
5.3.5 Research Institution
5.3.6 Y-o-Y Growth Analysis, By End User
5.3.7 Market Attractiveness Analysis, By End User
5.3.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technology
6.1.3.3 By Type
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technology
6.1.4.3 By Type
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technology
6.1.5.3 By Type
6.1.5.4 By End User
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Transasia Biomedicals ltd.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Abbott Laboratories
8.3 Alere Inc.
8.4 Arkray Inc.
8.5 Bio-Rad Laboratories Inc.
8.6 Danaher Corporation
8.7 F. Hoffmann-La Roche Ltd.
8.8 Siemens Healthcare
8.9 Trinity Biotech plc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
- Europe HbA1c Testing Market, By Type, From 2022 - 2027 (USD Million)
- Europe Hand Held Devices Market, By Region, From 2022 - 2027 (USD Million)
- Europe Bench Top Devices Market, By Region, From 2022 - 2027 (USD Million)
- Europe HbA1c Testing Market, By Technology, From 2022 - 2027 (USD Million)
- Europe Ion-Exchange High-performance Liquid Chromatography Market, By Region, From 2022 - 2027 (USD Million)
- Europe Enzymatic Assay Market, By Region, From 2022 - 2027 (USD Million)
- Europe Affinity Binding Chromatography Market, By Region, From 2022 - 2027 (USD Million)
- Europe Turbidimetric Inhibition Immunoassay Market, By Region, From 2022 - 2027 (USD Million)
- Europe Other Market, By Region, From 2022 - 2027 (USD Million)
- Europe HbA1c Testing Market, By End User, From 2022 - 2027 (USD Million)
- Europe Hospital Market, By Region, From 2022 - 2027 (USD Million)
- Europe Home Care Market, By Region, From 2022 - 2027 (USD Million)
- Europe Diagnostic laboratory Market, By Region, From 2022 - 2027 (USD Million)
- Europe Research Institution Market, By Region, From 2022 - 2027 (USD Million)
- U.K. HbA1c Testing Market, By Type, From 2022 - 2027 (USD Million)
- U.K. HbA1c Testing Market, By Technology, From 2022 - 2027 (USD Million)
- U.K. HbA1c Testing Market, By End User, From 2022 - 2027 (USD Million)
- Germany HbA1c Testing Market, By Type, From 2022 - 2027 (USD Million)
- Germany HbA1c Testing Market, By Technology, From 2022 - 2027 (USD Million)
- Germany HbA1c Testing Market, By End User, From 2022 - 2027 (USD Million)
- France HbA1c Testing Market, By Type, From 2022 - 2027 (USD Million)
- France HbA1c Testing Market, By Technology, From 2022 - 2027 (USD Million)
- France HbA1c Testing Market, By End User, From 2022 - 2027 (USD Million)
- Italy HbA1c Testing Market, By Type, From 2022 - 2027 (USD Million)
- Italy HbA1c Testing Market, By Technology, From 2022 - 2027 (USD Million)
- Italy HbA1c Testing Market, By End User, From 2022 - 2027 (USD Million)
- Spain HbA1c Testing Market, By Type, From 2022 - 2027 (USD Million)
- Spain HbA1c Testing Market, By Technology, From 2022 - 2027 (USD Million)
- Spain HbA1c Testing Market, By End User, From 2022 - 2027 (USD Million)
Related Reports
ASK FOR CUSTOMIZATION
Talk to our analyst and get customised report done according to your research needs
INQUIRE FOR DISCOUNT
Check if you can avail any discount. Submit your details and our team will get back to you.
DOWNLOAD FREE SAMPLE
Request to avail a free sample report that reflects this market and its growth.
